A Trial of Dextromethorphan for Treatment of Major Depressive Disorder

Phase 1 Completed 4 enrolled Medical University of South Carolina

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A proof-of-concept study to determine the antidepressant potential of Dextromethorphan for treating depression associated with Major Depressive Disorder in inpatients.

Timeline

Start: 2016-08
Primary completion: 2017-06
Completion: 2017-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Dextromethorphan	Unknown	75 mg	Oral

A Trial of Dextromethorphan for Treatment of Major Depressive Disorder

Summary

Timeline

Drugs

Indications